DL002

DL002 is an ADC linker used to synthesize antibody-drug conjugates that incorporate BCL-2 family protein degraders, intended for cancer research applications.

C(C1=C(CCC(C)(C)C1)C2=CC=C(Cl)C=C2)N3CCN(CC3)C4=CC=C(C(NS(=O)(=O)C5=CC(S(C(F)(F)F)(=O)=O)=C(N[C@H](CCN6CCN(C(CCCCCC(N[C@H](C(=O)N7[C@H](C(N[C@@H](C)C8=CC=C(C=C8)C=9SC=NC9C)=O)C[C@@H](OC(OCC%10=CC=C(NC([C@@H](NC([C@@H](NC(CCCCCN%11C=C(N=N%11)C=%12C=NC(S(C)(=O)=O)=NC%12)=O)[C@H](C)C)=O)CCCCN)=O)C=C%10)=O)C7)[C@](C)(C)C)=O)=O)CC6)CSC%13=CC=CC=C%13)C=C5)=O)C=C4